What is a Urethral Stricture?
A urethral stricture is scarring in the urethra or surrounding tissue that narrows or blocks the passageway through which urine flows from the bladder. The stricture can result from inflammation, infection or injury, and is much more common in men than in women. The scarring can occur anywhere between the bladder and the tip or opening of the urethra. In addition to uncomfortable urinary symptoms such as reduced flow rate and frequent urination, a urethral stricture can lead to complications that include urinary tract infections, prostatitis, urinary retention and kidney damage.
Urotronic ROBUST III Study
The purpose of this study is to assess the safety and efficacy of a drug-coated balloon (DCB) in the treatment of anterior urethral strictures.
What is a drug-coated balloon and how is it used?
A DCB is a small cylindrical balloon, coated in medication that is engineered to slow or stop the development of scar tissue that causes urethral strictures. The investigational treatment takes about fifteen minutes and is done on an outpatient basis. DCBs have been successfully used in cardiovascular procedures for several years and have proven to effectively reduce the need for re-treatment.
Patients may be eligible to participate in a study if:
- they’ve been diagnosed with a stricture
- had prior treatments
- experienced significant symptoms of stricture such as frequency of urination, urgency and slow flow of urine